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The global rate of intensive care unit (ICU) admission during the COVID-19 pandemic varies
within countries and is among the main challenges for health care systems worldwide. Con-
flicting results have been reported about the response to coronavirus infection and COVID-
19 outcomes in men and women. Understanding predictors of intensive care unit admission
might be of help for future planning and management of the disease.
Methods and findings
We designed a cross-sectional observational multicenter nationwide survey in Italy to under-
stand gender-related clinical predictors of ICU admission in patients with COVID-19. We
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analyzed information from 2378 charts of Italian patients certified for COVID-19 admitted in
26 hospitals. Three hundred ninety-five patients (16.6%) required ICU admission due to
COVID19 infection, more frequently men (74%), with a higher prevalence of comorbidities
(1,78±0,06 vs 1,54±0,03 p<0.05). In multivariable regression model main predictors of
admission to ICU are male gender (OR 1,74 95% CI 1,36–2,22 p<0.0001) and presence of
obesity (OR 2,88 95% CI 2,03–4,07 p<0.0001), chronic kidney disease (OR: 1,588; 95%,
1,036–2,434 p<0,05) and hypertension (OR: 1,314; 95% 1,039–1,662; p<0,05). In gender
specific analysis, obesity, chronic kidney disease and hypertension are associated with
higher rate of admission to ICU among men, whereas in women, obesity (OR: 2,564; 95%
CI 1,336–4.920 p<0.0001) and heart failure (OR: 1,775 95% CI: 1,030–3,057) are associ-
ated with higher rate of ICU admission.
Conclusions
Our study demonstrates that gender is the primary determinant of the disease’s severity
among COVID-19. Obesity is the condition more often observed among those admitted to




The global rate of intensive care unit (ICU) admission during the COVID-19 pandemic varies
within countries and is among the main challenges for health care systems worldwide. Under-
standing predictors of ICU admission might be of help for future planning and management
of the disease. The clinical response to coronavirus infection in men and women appears to be
different according to scientific reports [1]. A gender-specific analysis has not yet been carried
out, while most recently, researchers’ attention focused on pregnant women infected by
SARS-Cov2 infection [2].
In China, the gender distribution was equal in a group of 140 patients with COVID-19 [3],
and in a subsequent report of 1099 patients with COVID-19 from 552 hospitals in 30 Chinese
provinces, 58% of the patients were men [4]. Some more recent data from the New York City
area show a lower prevalence of women, and confirm lower mortality for different age range
[5]. Female gender seems to represent a protective factor for in-hospital mortality [odds ratio
0.79 (CI 0.65–0.95)] in an extensive observational database collecting patients from Asia,
Europe, and the United States [6].
Among critically ill patients, fewer women were affected than men in China [7] and Italy
[8] (33 and 18% respectively). The analysis of gender-disaggregated data has shown a similar
number of men and women affected by the disease, although mortality seems to be higher in
men. It has been suggested that the observed male gender predisposition could be explained
by the higher proportion of smokers in men than in women [9]. In addition to lifestyle habits,
other gender-related aspects, including enzymatic activity, metabolism and immunology, and
drug response, have been evoked as potential explanations for these observations [10].
In the last few months, it has become clear that Age and multimorbidity are the significant
determinants of more severe clinical manifestation of the disease [11–13]. Some authors also
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hypothesize that ACE inhibitors and Angiotensin Receptor Antagonist (ARB) can induce pro-
tection from COVID-19 [14].
To the best of our knowledge, whether gender-related differences in clinical characteristics,
comorbidities, and treatment may affect an adverse outcome is still not established. Neverthe-
less, such a piece of information is very much expected and called for [15]. Accordingly, we
explored the influence of gender-related differences, comorbidities, and treatment on clinical
predictors of ICU admission in patients with COVID-19.
Methods and findings
Study population
The SARS-RAS is a cross-sectional, multicenter, observational study conducted in 26 hospitals
and centers in Italy [13]. The centers were distributed in 13 regions, each contributing accord-
ing to the detailed geographical distribution of the disease, most of the patients being located
in Northern regions, especially Lombardy, compared to Southern regions. The patients’ cohort
included 2378 patients aged 18 to 101 years with confirmed COVID-19, according to World
Health Organization interim guidance [16]. The observation period started on March 9th and
ended on April 29th, 2020. The study is performed under the article 89 of the General Data Pro-
tection and Regulation, which allows the processing of personal data for archiving purposes in
the public interest, scientific or historical research purposes or statistical purposes, provided
that technical and organizational measures are in place to ensure the principle of data minimi-
zation (https://gdpr-info.eu). The SARS-RAS study is registered in Clinicaltrials.gov at the
accession number NCT04331574.
Procedures
An online questionnaire was distributed among the centers to collect reviewed epidemiologi-
cal, clinical, and outcomes data from hospital emergency rooms, regular and intensive care
wards. Each center designated at least one physician that was instructed to the acquisition and
review of the requested information. Patients were pseudonymized by assigning a deidentified
identification code. The questionnaire collected information regarding the center and the Age,
gender, nationality (Italian or other), and city of origin of the patient. From the anamnesis, we
collected whether the patient had a known diagnosis of hypertension with prescribed antihy-
pertensive drugs, coronary artery disease (history of myocardial Infarction, PCI or CABG),
heart failure (based on clinical history), diabetes (with prescribed antidiabetic drugs), chronic
kidney disease [based on anamnestic estimated glomerular filtration rate (eGFR) below 60 ml/
min/kg], chronic obstructive pulmonary disease (based on the presence of signs and symptoms
according to GOLD 2019), obesity (body mass index�30 Kg/m2 according to the Center for
Disease Control and Prevention; https://www.cdc.gov/obesity/adult/defining.html), history of
blood and solid tumors, liver disease, and other comorbidities; pharmacological treatment as
regards the use of RAS inhibitors (ACE inhibitors, ARBs) and other antihypertensives; the
degree of the severity of COVID-19 [17]. The electronic data was transmitted with the modern
cryptography systems over the web and stored in a locked, password-protected computer. All
collected records were then quality checked by two authors (G.I and C.M.).
COVID-19 diagnosis was confirmed in all patients by RT-PCR performed on nasopharyn-
geal or throat swab samples [18] in each center by the designated Institutions.
We also collected the outcomes (hospital dismission or death) if available at the time point
of the survey. All patients for which the course of the disease was in an active state, were classi-
fied as such [16].
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Statistical analysis
Descriptive analyses of the variables were expressed as mean and standard errors (S.E.) or fre-
quencies expressed in absolute numbers and percentages. We used ANOVA to analyze continu-
ous variables, and the χ2 test or the Kruskal Wallis test as appropriate to compare categorical
data. We tested regression analyses, odds ratio, and confidence intervals on the interest variables
grouped by admission or non-admission to the intensive care unit (ICU). We performed multi-
variable regression analyses on the significant and clinically relevant continuous and categorical
variables to assess the primary determinant of ICU admission. We applied the same model after
grouping the study population by gender. p<0.05 was considered statistically significant.
Results
Answers to all questions of the questionnaire were mandatory before the online form could be
validated. We collected 2409 questionnaires. After a quality check, 2378 were used for the anal-
ysis. Reasons for discharge were incongruences between the responses or duplication. The
average Age was 68,21±0,38 years, and 1489 (62.6%) were men; patients were prevalent of Ital-
ian nationality (94%). Patients presented with several comorbidities including hypertension,
diabetes, chronic obstructive pulmonary disease, coronary artery disease, heart failure, obesity,
chronic kidney disease; the prevalence of diabetes, coronary artery disease, and chronic kidney
disease was lower in women than in men while, as expected, thyroid diseases were more preva-
lent in women (Table 1). Women took fewer ACE inhibitors and alpha-blockers and more
diuretics than men (Table 2).
Of the total study population, 395 patients entered ICUs. These patients were more fre-
quently men, with a higher prevalence of obesity, hypertension, diabetes, chronic kidney dis-
ease, and heart failure (all p<0.05, Table 1).
The use of ACE inhibitors or ARBs medications did not differ among patients admitted or
not admitted to ICU. Interestingly, ACE inhibitors were less used, while diuretics were more
often prescribed in women admitted to ICUs (Table 2).
The rate of admission in ICU was higher for males, compared to females (19,5 vs 11.7%,
p<0.0001). Compared to men, women admitted to ICU were older, with a more considerable
prevalence of heart failure. (Table 3, Fig 1, panel A and B).







p Admitted to ICU
(n = 395)
Not admitted to ICU
(n = 1983)
p
Age (years) 68,2141±0,38 66,9±0,39 70,3±0,77 0,0005 68.9±0.70 68.1±0.43 0,418
Men (%) 62.6 73.7 60.4 0.0005
Hypertension (%) 58.5 58.8 58.0 0,689 65,3 57.2 0.003
Obesity (%) 6,6 6,7 6,5 0.861 12.4 5.5 0.0001
Diabetes (%) 18,2 19,8 15,5 0.009 22,8 17,3 0.01
COPD (%) 8,5 8,9 7,5 0.280 10.4 8.1 0.132
CKD (%) 6.1 6,4 4.3 0.031 8.6 5.0 0.004
Coronary artery disease
(%)
14.3 16,9 10.0 0.0005 15,7 14,1 0.153
Heart Failure (%) 12.1 11,9 12,4 0.716 15.2 11,6 0.05
Thyroid Disease (%) 0,2 0,1 0,5 0,049 0,0 0,3 0,318
COPD: Chronic obstructive pulmonary disease; CKD: Chronic kidney disease; p-value for Age was calculated by unpaired t-test; for categorical variables, the χ2 test was
used.
https://doi.org/10.1371/journal.pone.0237297.t001
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In the multivariable regression model, the main predictors of admission to ICU were male
gender, obesity, hypertension, and chronic kidney disease (Table 4, Fig 2, panel A).
In the gender-specific analysis, among men, obesity, hypertension, and chronic kidney dis-
ease were associated with a higher rate of admission to ICU (Fig 2, panel B). Similarly, among
women, obesity and heart failure were associated with a higher rate of ICU admission (Fig 2,
panel C).
Discussion
Admission to ICU has been a significant challenge for all health care systems, fighting the
COVID-19 pandemic. The percentage of patients admitted to ICU differs among countries,
ranging from 5 to 32% in China and 5 to 10% in Italy. Knowledge of clinical characteristics of
patients admitted to ICU is of crucial importance for future management of the disease, with
specific regards to the prevention and surveillance of active patients with mild to moderate dis-
ease. Our study demonstrates that the main determinants of ICU admission are male gender
and obesity and that patients admitted to ICU have more comorbidities than those not-admit-
ted to ICU. Furthermore, a gender-specific phenotype of patients admitted to ICU exists since
men are more often obese, hypertensive, and affected by chronic kidney disease, while women
are older than men and present with obesity and heart failure.







p Admitted to ICU
(n = 395)





22.2 24,3 18,6 0,001 24,6 21.7 0.211
ARBs (%) 18.6 17,7 20,2 0,141 16,7 19.1 0.281
β-blockers (%) 23.6 24,2 22,5 0,358 24.3 23.4 0.703
Ca-Antagonists
(%)
8,1 8,2 8,0 0,864 7,8 8.2 0.829
Diuretics (%) 15,4 14,2 17,4 0,042 14,7 15,5 0.667
α-blockers 1,9 2,9 0,2 0,001 1,8 1,9 0,847
ACE: Angiotensin-converting enzyme; ARB: Angiotensin II Receptor 1 Blockers; β-Adrenergic receptor blockers p values for categorical variables, were calculated by
the χ2 test.
https://doi.org/10.1371/journal.pone.0237297.t002
Table 3. Characteristics of the ICU population.
Admitted to ICU (n = 395) Males (n = 291) Females (n = 104) p
Age (years) 68.9±0.70 67,4±0,81 73,0±1,4 0,001
Men (%) 73.7
Hypertension (%) 65,3 65,3 65,4 0,986
Obesity (%) 12,4 12,0 13,5 0,703
Diabetes (%) 22,8 23,4 21,2 0,644
COPD (%) 10.4 9,6 12,5 0.409
CKD (%) 8.6 9,3 6,7 0,427
Coronary artery disease (%) 15,7 16,8 12,5 0.297
Heart Failure (%) 14,4 12,4 23,1 0,001
Thyroid Disease (%) 0,0 0 0 1
COPD: Chronic obstructive pulmonary disease; CKD: Chronic kidney disease; p-value for continuous variable Age was calculated by unpaired t-test; for categorical
variables, the χ2 test was used.
https://doi.org/10.1371/journal.pone.0237297.t003
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Clinical characteristics and outcomes of COVID-19 patients differ by gender: males are
more prevalent, especially among those admitted to ICU [19] and associated with increased
disease severity [20]. A recent study from Meng et al. identified gender-specific differences in
disease incidence and fatality rate, related to more severe kidney and liver function abnormali-
ties in male patients [21]. A recent meta-analysis, including more than 59.000 patients identi-
fied male gender and older Age as the main predictors of mortality [22]. All these findings, in
line with our results, strongly suggest that a gender-specific susceptibility to the infection and
disease progression exists. Women—even in postmenopausal Age—seem to be protected
against COVID-19 as well as against worse outcomes. A biological mechanism may explain
the higher risk of men. The ability of androgens to regulate transmembrane protease serine 2
[23], i.e. the enzyme allowing the final interaction between ACE2 and SARS-CoV-2 and viral
RNA entry into the cell, might take part in this mechanism [24]. Also, data from animal studies
with SARS-CoV infection have identified more enhanced virus replication and alveolar dam-
age in male mice, mainly due to enhanced and ineffective cytokine response [25].
Recent reports from different countries have highlighted the importance of obesity as pri-
mary comorbidity in COVID19 patients leading to ICU admission and deaths [26]. During
H1N1 influenza in 2010, different reports identified obesity as the main risk factors for hospi-
talization and deaths [27]. Obesity is associated with reduced respiratory function due to
decreased expiratory reserve, functional capacity, and respiratory system compliance [28]. Fur-
thermore, adipose tissue is involved in complex interactions with the immune system. Release
of inflammatory adipokines from visceral fat depots can affect the immune response and con-
tribute to the imbalance between anti and pro-inflammatory adipokines secretion from tho-
racic visceral fat depots [29]. There is also evidence that obesity impaired adaptive immune
response to seasonal influenza virus [30]. This complex scenario can partially explain the cyto-
kine storm described in patients with severe SARS-CoV infection.
The coexistence of male gender and obesity may trigger a maladaptive, exaggerated
immune response, leading to the development of acute respiratory distress syndrome, and an
increased frequency of ICU admission. Also, among women, admission to ICU was associated
Fig 1. Panel A Patients admitted to ICU were 395: Women (n = 104) were older than men (n = 291); � p<0,05,
unpaired t test. Panel B Men and women admitted at the ICU presented a similar number of comorbidities
(hypertension, coronary artery disease, heart failure, diabetes, chronic kidney disease, chronic obstructive pulmonary
disease, obesity, history of blood and solid tumors, liver disease).
https://doi.org/10.1371/journal.pone.0237297.g001
Table 4. Multivariable logistic regression analysis for ICU admission in the total study population.
Univariate Analysis Multivariable Analysis
Model 95% CI
p Pearson p Beta
Age 0.425 0.016
Gender (M/F) 0.001 -0.102 0.0001 1.876 1.415–2.304
Hypertension (y/n) 0.003 0,061 0.023 1.314 1.039–1.662
Diabetes (y/n) 0.01 0,053 0.493 1.174 0.891–1.547
CKD (y/n) 0.005 0,058 0.034 1.588 1.036–2.434
Heart failure (y/n) 0.05 0,040 0.554 1.117 0.804–1.551
CAD (y/n) 0.400 0.017
Obesity (y/n) 0.001 0,103 0.0005 2.476 1.724–3,555
ICU: intensive care unit; CKD: Chronic kidney disease; CAD: Coronary Artery Disease
https://doi.org/10.1371/journal.pone.0237297.t004
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Fig 2. Panel A: Forrest plot of the odds ratio and confidence intervals calculated for each variable found to be
independently associated with ICU admission in the total study population. Panel B: Forrest plot of the odds ratio and
confidence intervals calculated for each variable found to be independently associated with ICU admission among
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with obesity, supporting the role of decreased inflammatory protection caused by the accumu-
lation of adipose tissue and by increasing Age. With older Age, females develop stronger
chronic immune reactions in the myocardium [31]. Heart failure in women, by raising left
ventricle filling pressures, could cause a higher frequency of pulmonary complications and
hypoxic respiratory failure requiring mechanical ventilation in ICU. Also, sex hormones may
affect many components of the renin-angiotensin-aldosterone system, including ACE2. A very
recent report shows that women with heart failure have lower plasma ACE2 levels than men
[32], although the evidence of the relationship among circulating and tissue concentrations of
ACE2 is still missing. In our population, women received fewer ACE inhibitors and more
diuretics than men. ACE-inhibitors might exert protection by reducing the production of
Angiotensin II, which in turn sustains the pro-inflammatory response [33, 34]. It is possible,
therefore, to speculate that reduced use of ACE inhibitors in women also provides reduced
protection from COVID-19; at the same time, greater exposure to diuretics could increase the
risk of hypokalemia.
Our study has limitations. Firstly, the use of questionnaires might allow for some level of
uncertainty. The online questionnaire was designed with closed answers, all necessary for final
validation of the form, therefore reducing the risk of incomplete answers. Secondly, the pres-
ent study includes only symptomatic, hospitalized patients. We excluded subjects with not
confirmed disease by nasal or pharyngeal swabs. Therefore, we might have missed those
patients with early infection and negative tests. Also, the cross-sectional and not prospective
design of our study does not allow us to identify a causative role for the reported parameters
on the outcomes.
Nevertheless, our study is compelling in generating hypotheses to be further demonstrated
in extensive prospective studies.
Conclusions
Our study demonstrates a gender effect for women in COVID-19 that are protected from
more severe clinical presentations of the disease. In women, heart failure and obesity are more
strictly associated with ICU admission.
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